Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
about
Herbal preparations for uterine fibroidsProgestogen only versus combined oral contraceptive pills for fibroid related heavy menstrual bleedingAcupuncture for uterine fibroidsHerbal preparations for uterine fibroidsAcupuncture for uterine fibroidsProceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsEmbolization of uterine fibroids from the point of view of the gynecologist: pros and cons.Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri).Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUSNon-contraceptive applications of the levonorgestrel intrauterine system.Levonorgestrel-releasing intrauterine system: uses and controversies.Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.The role of progesterone signaling in the pathogenesis of uterine leiomyomaLevonorgestrel intrauterine system (Mirena): An emerging tool for conservative treatment of abnormal uterine bleeding.The levonorgestrel-releasing intrauterine system in modern gynaecology.Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system.Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.Uterine fibroids: clinical manifestations and contemporary management.Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding.Updated approaches for management of uterine fibroidsThe levonorgestrel intrauterine system: long-term contraception and therapeutic effects.The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial.A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
P2860
Q24197590-5FCA5D03-26CC-4E52-8277-D3EAE2CFBB72Q24201475-A8634032-ABD0-423B-8F89-BB85DACE2FF9Q24240757-FBD7D568-49FE-4827-92C2-27EC0EF2EF36Q24241248-259C1436-D188-426B-B744-12BAFD64F712Q24242591-6AD039E1-A034-4159-BF99-DE549941E3F5Q24567733-B464B16A-42A9-4326-A8D2-3A9BFF592F92Q33817053-28C09F3D-4E83-4009-B835-3B18CDD1C4B7Q34001985-F75B8514-FAD8-46CA-A023-B23B285F080BQ34049773-13FAAE38-7B77-44BF-9448-A4F19ACA4DE6Q34272031-1199A5CF-7E81-4465-9E58-3C7971061A96Q34272077-948D0461-F6B2-42C9-83CF-BEE1190AB9A3Q34788317-7AA65457-7241-46BF-9106-3110964C3470Q35240186-6E9D7326-57D2-4BC2-9268-6C72A15294ADQ35249360-7DAE7EB7-B01A-4334-89DC-7C100D8D3BC0Q35313822-BF31A721-6639-4028-9029-48F3025ABF63Q36299701-25383A63-B54A-466A-86B1-72239D97D27DQ36984317-1C74F94A-6243-4C6C-A549-B58D5631618DQ37199883-E12C6629-D8F4-4FD8-AE88-B04884F1A20EQ37946922-F56AC2FE-F4C9-4F43-B26F-CB7E4678B540Q37977978-9769EEAB-64F1-414F-8299-5CAF9C83522FQ38211241-CA6ED8BD-F5CD-4FE1-B636-384F6BA8AB13Q38513642-369E0525-D223-468B-885A-718A281D31E8Q39878679-94792C2C-1DF7-4342-8B00-148CAF351DE3Q41385417-9F8C42C0-40D3-49B4-81A7-CE8BF4B309C0Q43267079-EB107803-E9B9-4629-9361-537976E7C11AQ44767615-AEFD5F05-CAE2-407F-8262-A9E24449D7D5Q45065757-B5780844-F1BE-4DD5-AAB3-279CC6D118B4Q46967146-04F07A16-F5A5-4AFE-A1B6-E6DFE0F0FBDAQ47119285-E5053D32-03F7-48A7-B5EA-8B5FD6EB5A9AQ47837409-D99684BF-A1E3-44CE-8AC0-FCE3CB7555E3Q48246625-65D3818D-39CE-44D7-9F10-E1081FD2BFF8
P2860
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@en
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@nl
type
label
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@en
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@nl
prefLabel
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@en
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@nl
P2093
P1476
Use of a levonorgestrel-releas ...... related to uterine leiomyomas.
@en
P2093
Marina Tarasova
Mario Chen-Mok
Vera Grigorieva
P304
P356
10.1016/S0015-0282(03)00175-4
P407
P577
2003-05-01T00:00:00Z